Table 4 Number and weighted proportions for age- appropriate and complete immunization of the study population
| Â | Age appropriate immunization at: | Complete immunization | ||
|---|---|---|---|---|
Vaccine | 12 months | 24 months | 60 months | (n=731) |
(n=731) | (n=704) | (n=56) | ||
| Â | N (%) | N (%) | N (% ) | N (%) |
DTP/DTaP | 696 (95.4) | 594 (84.8) | 19 (33.7) | 688 (94,2) |
OPV /IPV | 629 (86.8) | 602 (86.2) | 22 (38.8) | 723 (98.9) |
Hib | 688 (94.2) | 559 (80.0) | 37 (65.6) | 691 (94.5) |
MMR | - | 660 (90.5) | 20 (35.9) | 462 (63.7) |
HBV | 202 (27.7) | 605 (86.1) | 55 (97.4) | 688 (94.3) |
MenC | 164 (22.9) | 111 (16.1) | 7 (12.4) | 671 (91.9) |
PCV7 | 113 (16.0) | 66 (9.8) | 2 (4.0) | 537 (73.1) |
Var | - | 430 (60.4) | 17 (30.1) | 435 (61.1) |
HAV | - | 6 (0.9) | 41 (71.7) | 450 (62.0) |
All 5 traditional vaccines* (DTP/DTaP, OPV/ IPV, Hib, MMR, HBV) | 163 (22.6) | 417 (60.1) | 4 (6.8) | 414 (56.9) |
All 3 new* (PCV7, Var, MenC) | 62 (8.8) | 35 (5.2) | 1 (2.0) | 327 (44.2) |